GURUFOCUS.COM » STOCK LIST » Technology » Software » ReadyTech Holdings Ltd (ASX:RDY) » Definitions » Net Change in Cash

ReadyTech Holdings (ASX:RDY) Net Change in Cash : A$3.9 Mil (TTM As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is ReadyTech Holdings Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

ReadyTech Holdings's Net Change in Cash for the six months ended in Dec. 2023 was A$-5.7 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 was A$3.9 Mil.

ReadyTech Holdings Net Change in Cash Historical Data

The historical data trend for ReadyTech Holdings's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ReadyTech Holdings Net Change in Cash Chart

ReadyTech Holdings Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23
Net Change in Cash
0.74 2.89 2.78 -2.79 11.42

ReadyTech Holdings Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -4.17 1.37 1.79 9.63 -5.70

ReadyTech Holdings Net Change in Cash Calculation

ReadyTech Holdings's Net Change in Cash for the fiscal year that ended in Jun. 2023 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=27.806+-27.778+11.387+0
=11.4

ReadyTech Holdings's Net Change in Cash for the quarter that ended in Dec. 2023

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=14.136+-14.877+-4.957+0
=-5.7

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$3.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ReadyTech Holdings Net Change in Cash Related Terms

Thank you for viewing the detailed overview of ReadyTech Holdings's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

ReadyTech Holdings (ASX:RDY) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Technology » Software » ReadyTech Holdings Ltd (ASX:RDY) » Definitions » Net Change in Cash
Comparable Companies
ASX:NXL ASX:RUL ASX:BVS ASX:IFM ASX:SYM ASX:C79 ASX:DSE ASX:BTH ASX:IOD ASX:TSK CRM XTER:SAP INTU NOW UBER CDNS SHOP WDAY XPAR:DSY ROP
Traded in Other Exchanges
N/A
Address
77 King Street, Level 2, Sydney, NSW, AUS, 2000
Website
https://www.readytech.com.au
ReadyTech Holdings Ltd is a provider of people management software for educators, employers, and facilitators of career transitions. Its products are JR Plus, A2E, HR3, ePayroll, JR Gov, Aussiepay, and others. The company's operating segments include Education and Work pathways, Workforce Solutions, and Government and Justice. It generates maximum revenue from the Education segment. The education segment mainly provides products and services to tertiary education providers. Its Workforce segment provides products and services to a mid-sized company across various industries. The Government division provides government and justice case management software as a service solution to local governments, state governments and justice departments.

ReadyTech Holdings (ASX:RDY) Headlines

From GuruFocus

Dr. Reddy's Successfully Completes Phase I Study (IV Route) of DRL_TC, a Proposed Biosimilar of Tocilizumab

By Business Wire Business Wire • 06-05-2023

Dr. Reddy's successfully completes full set of clinical studies of its rituximab biosimilar for filing in the U.S., Europe

By Business Wire Business Wire • 01-20-2023

Dr. Reddy's Laboratories Announces the Acquisition of an Injectable Product Portfolio from Eton Pharma

By Business Wire Business Wire • 06-24-2022

Dr. Reddy's Laboratories Announces the Launch of Pemetrexed for Injection USP, in the U.S. Market

By Business Wire Business Wire • 05-27-2022

Dr. Reddy's Laboratories Announces its Launch of Saxagliptin and Metformin Hydrochloride Extended-Release Tablets in the U.S.

By Business Wire • 08-10-2023

Dr. Reddy's Laboratories Enters Into Definitive Agreement to Acquire German Medical Cannabis Firm Nimbus Health GmbH

By Business Wire Business Wire • 02-03-2022

Dr. Reddy's Laboratories and MediCane Health Announce the Launch of Medical Cannabis Products in Germany

By Business Wire Business Wire • 04-01-2022

Aurigene Discovery Technologies Limited Announces Drug Discovery, Development and Commercialization Partnership with EQRx

By Business Wire Business Wire • 07-05-2022

Dr. Reddy's Laboratories enters into a licensing agreement with Slayback Pharma to obtain exclusive rights in the first-to-file ANDA for the private label version of Lumify� in the U.S.

By Business Wire Business Wire • 07-29-2022

Dr. Reddy's Laboratories Announces the Launch of Regadenoson Injection 0.4 mg/5 mL in the U.S.

By Business Wire Business Wire • 05-05-2023